Abstracts

Citation

Elisa Nemes, Varghese George, Thomas Scriba, Willem Hanekom, Mark Cotton, Bonnie Zimmer, Terry Felton, Paula Britto, Savita Pahwa , IMPAACT P1073 team. Risk factors for BCG IRIS in HIV-infected infants starting antiretroviral therapy. Presented at: CROI 2016; 2016 Feb 24.

Citation

A Gupta, L Aaron , G Theron, K McCarthy, S Bradford, T Chipato, T Vhembo, L Stranix-Chibanda, C Onyango-Makumbi , G Masheto, N Chakhtoura, P Jean-Phillippe , R Browning , T Sterling, A Weinberg, G Montepiedra, IMPAACT P1078 TB APPRISE Study Team. Risk factors for hepatotoxicity in HIV-infected women receiving isoniazid preventive therapy in pregnancy and postpartum. Presented at: International AIDS Conference.

Citation

D Sebikari, M Qin, M Owor, J Stringer, M Farhad, N Chakhtoura, B Chi, K Klingman, G Theron, MG Fowler. Risk factors for low birth weight and preterm delivery in the PROMISE trial. Presented at: CROI 2017; 2017 Feb 16.

Citation

John S. Lambert, M.D., Lynne M. Mofenson, M.D., F.A.A.P., E. Richard Stiehm, M.D., James Bethel, Ph.D., William A. Meyer, III, Ph.D., Patricia Reichelderfer, Ph.D., George J. Nemo, Ph.D. Risk Factors for Perinatal HIV Transmission in Women/Infants Receiving Standard Zidovudine (ZDV) Prophylaxis.

Citation

John J. Farley, M.D., M.P.H., Katherine Tassiopoulos, Sc.D., M.P.H., Paige L. Williams, Ph.D., Marilyn Jean Crain, M.P.H., M.D., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H. Risk of hypercholesterolemia over time among perinatally-infected children in pediatric AIDS clinical trials group (PACTG) 219C - iDACS 603B. Presented at: XVI International AIDS Conference.

Citation

Sean S Brummel, Lauren Ziemba, Anne Coletti, Lameck Chinula, Chelsea Krotje, Renee Browning, Patrick Jean Philippe, Nahida Chakhtoura, Esaú Custódio João, Mpho Raesi, James Samwel Ngocho, Linda Aurpibul, Lynda Stranix-Chibanda, Roger Shapiro, Jeff Stringer, Shahin Lockman. Risk-benefit Trade-off for Pregnancy and Infant Outcomes: DTG, EFV, TAF, and TDF. Presented at: CROI 2022; 2022 Feb 15.

Citation

Patricia Flynn, Taha Taha, Mae Cababasay, Kevin Butler, Mary Glenn Fowler, Lynne Mofenson, Maxensia Owor, Susan Fiscus, Lynda Stranix-Chibanda, Anna Coutsoudis, Devasena Gnanashanmugam, Nahida Chakhtoura, Katie McCarthy, Cornelius Mukuzunga, Bonus Makanani, Dhayendre Moodley, Teacler Nematadzira, Bangini Kusakara, Sandesh Patil, Tichaona Vhembo, Raziya Bobat, Blandina Mmbaga, Maysseb Masenya, Mandisa Nyati, Gerhard Theron, Helen Mulenga, David Shapiro, PROMISE Study Team. Role of maternal viral load and CD4 count on perinatal HIV-1 transmission during breastfeeding in the PROMISE postpartum component. Presented at: IAS 2018.

Citation

Coleen K. Cunningham, Elizabeth J. McFarland, Edmund V. Capparelli, Petronella Muresan , Leavitt Morrison, Charlotte Perlowski , Megan Valentine , Betsy Smith , John R. Mascola, Barney Graham, IMPAACT P1112 team. Safety & Pharmacokinetics of Multiple Doses of a Potent Anti-HIV Monoclonal Antibody, VRC01, in HIV-Exposed Newborns. Presented at: CROI 2018.

Citation

CK Cunningham, EJ McFarland, EV Capparelli, P Muresan, C Perlowski, M Valentine, E Smith, JR Mascola, BS Graham. Safety & pharmacokinetics of the monoclonal antibody, VRC01, in HIV-exposed newborns. Presented at: CROI 2017; 2017 Feb 16.

Citation

RM Viani, C Alvero, T Fenton, E Acosta, R Hazra, E O'Gara, B Heckman, D McCarty-Steimers, S Min, A Wiznia. Safety and Efficacy of Dolutegravir in HIV Treatment-Experienced Adolescents: 48-Week Results. Presented at: CROI 2014; 2014 Mar 04.